Access cutting-edge diabetic retinopathy treatment through this clinical trial at a research site in Madison. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Madison location
Preparing your pre-screening questions…
Access diabetic retinopathy specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related diabetic retinopathy treatment provided free
Check if you qualify for this diabetic retinopathy clinical trial in Madison, WI
No-Cost Study Care
Local to Madison
Convenient for WI residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This pragmatic clinical trial is being conducted to test the effectiveness of AI-BRIDGE (Artificial Intelligence-Based point of caRe, Incorporating Diagnosis, SchedulinG, and Education), in improving screening and follow-up eye care compared to usual-care among patients with diabetes across 8 primary care clinics. AI-BRIDGE is an implementation program which includes an autonomous AI-based protocol that provides screening for diabetic retinopathy (DR) disease at primary care visits, as well as patient education on disease and, if a patient screens positive for referable DR or has insufficient quality image, or image unobtainable due to other technical issues, or does not get AI-screening for any reason, assistance with scheduling an in-person, follow-up eye-care visit.
Sponsor: University of Wisconsin, Madison
Yes, this clinical trial (NCT06763952) has an active research site in Madison, WI that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for diabetic retinopathy treatment options in Madison, WI, this clinical trial (NCT06763952) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Madison research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diabetic retinopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all diabetic retinopathy clinical trials near you to find additional studies recruiting in your area.
See all essential tremor clinical trials recruiting in Madison — not just this study.
Browse Essential Tremor Trials in Madison →